Related Experiment Videos
Lithium-induced nephrotic syndrome in a prepubertal boy
Carl E Petersen1, Sandra Amaral, Emily Frosch
1Navy Medicine Manpower Personnel Training and Education Command, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. carl.petersen@med.navy.mil
Journal of Child and Adolescent Psychopharmacology
|April 29, 2008
Summary
Lithium carbonate can cause kidney problems like nephrotic syndrome. A boy on lithium developed these symptoms, which resolved after stopping the medication, highlighting a potential link.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Psychopharmacology
Background:
- Lithium carbonate is a common mood stabilizer.
- Renal side effects of lithium, including nephrotic syndrome, are documented.
- Minimal change disease is a cause of nephrotic syndrome in children.
Observation:
- An 11-year-old boy with a mood disorder was treated with lithium carbonate.
- The patient presented with edema, pulmonary effusions, proteinuria, and hypoalbuminemia.
- These clinical features are consistent with nephrotic syndrome.
Findings:
- Renal biopsy confirmed minimal change disease.
- Discontinuation of lithium carbonate led to the normalization of symptoms.
- This case suggests a causal relationship between lithium and minimal change disease.
Implications:
- Lithium therapy requires careful renal function monitoring in pediatric patients.
- Minimal change disease should be considered in children on lithium presenting with nephrotic symptoms.
- Understanding lithium's nephrotoxicity is crucial for safe psychopharmacological practice.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:29Diabetes Insipidus I: Introduction
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...